Short-term effects of high soy supplementation on sex hormones, bone markers, and lipid parameters in young female adults

European Journal of Nutrition

Volumn 43, Issue 2, 2004, Pages 100-108

  Zittermann, Armin ^a   Geppert, Julia ^a   Baier, Sonja ^a   Zehn, Nicole ^a   Gouni Berthold, Ioanna ^a   Berthold, Heiner K ^b   Reinsberg, J ^a   Stehle, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Drug Commn of the Ger Med Assoc   (Germany)

Author keywords

Bone turnover; Isoflavones; Menstrual cycle; Soy

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PROGESTERONE; SEX HORMONE;

ARTICLE; BONE TURNOVER; BREAST CANCER; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OVULATION; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

ADULT; BIOLOGICAL MARKERS; BONE RESORPTION; CALCIUM; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GONADAL STEROID HORMONES; HUMANS; LIPIDS; REFERENCE VALUES; SOYBEAN PROTEINS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

GLYCINE MAX;

EID: 2442703993     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-004-0447-5     Document Type: Article

References (44)

1. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE (1991) Dietary effects on breast-cancer risk in Singapore. Lancet 337:1197-1200
2. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W (2001) Population-based case-control study of soy-food intake and breast cancer risk in Shanghai. Br J Cancer 85:372-378
3. Schreiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8:384-392
4. Ota DM, Jones LA, Jackson GL, Jackson PM, Kemp K, Bauman D (1986) Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 57:558-562
5. Ettinger B (1988) Prevention of osteoporosis: treatment of estradiol deficiency. Obstet Gynecol 72:12S-17S
6. Nasr A, Breckwoldt M (1998) Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 12:43-59
7. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS (1999) Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 84:192-197
8. Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H (1998) Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 90:1830-1835
9. Lu LJ, Anderson KE, Grady JJ, Nagamani M (1996) Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 5:63-70
10. Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M (2000) Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 60:4112-4121
11. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L (1996) Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5:785-794
12. Cassidy A, Bingham S, Setchell KD (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333-340
13. Kurzer MS (2002) Hormonal effects of soy in premenopausal women and men. J Nutr 132:570S-573S
14. Ho SC, Chan SG, Yi Q, Wong E, Leung PC (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16:1363-1369
15. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852
16. Potter SM, Baum JA, Teng H, Stillmann RJ, Shay NF, Erdman JW (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S-1379S
17. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904-1912
18. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85:3043-3048
19. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282
20. Merz-Demlow BE, Duncan AM, Wangen KE, Xu X, Carr TP, Phipps WR, Kurzer MS (2000) Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71:1462-1469
21. Kuiper GGJM, Lemmen JG, Carlsson B, Corton C, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
22. Setchell KD, Cassidy A (1999) Dietary isoflavones: biological effects and relevance to human health. J Nutr 129:758S-767S
23. Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK (2003) Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr 57:(in press)
24. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18:499-505
25. Franke AA, Custer LJ, Wang W, Shi CY (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217:263-273
26. nd ed. Berlin: Springer Verlag, pp 374-441
27. Adlercreutz H, Mazur W (1997) Phytooestrogens and Western diseases. Ann Med 29:95-120
28. Cassidy A, Bingham S, Setchell K (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 74:587-601
29. rd, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076
30. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N, Shimizu H (2000) Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31:308-314
31. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124:825-832
32. Lu LJ, Lin SN, Grady JJ, Nagamani M, Anderson KE (1996) Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. Nutr Cancer 26:289-302
33. Heynck H, Krampitz G, Hesse A (1995) Binding of calcium by brans under simulated gastrointestinal pH conditions. In vitro study with 45Ca. Eur J Clin Nutr 49(Suppl 3):S250-252
34. Zittermann A, Schwarz I, Scheld K, Sudhop T, Berthold HK, von Bergmann K, van der Ven H, Stehle P (2000) Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women. J Clin Endocrinol Metab 85:95-101
35. Mauras N, Vieira NE, Yergey AL (1997) Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study. Metabolism 46:908-913
36. Halleen J, Alatalo S, Janckila A, Heikkinen J, Väänänen K (2000) A novel immunoassay for serum tartrate-resistent acid-phosphatase 5b. Calcif Tissue Int 66(suppl):S85
37. Wichers M, Schmidt E, Bidlingmaier F, Klingmuller D (1999) Diurnal rhythm of CrossLaps in human serum. Clin Chem 45:1858-1860
38. Gundberg CM, Markowitz ME, Mizruchi M, Rosen JF (1985) Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 60:736-739
39. Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not in premenopausal women. J Clin Endocrinol Metab 86:5217-5221
40. Tonolo G, Ciccarese M, Brizzi P, Milia S, Dessole S, Puddu L, Secchi G, Maioli M (1995) Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women. Am J Physiol 269: E1101-E1105
41. Muesing RA, Forman MR, Graubard BI, Beecher GR, Lanza E, McAdam PA, Campbell WS, Olson BR (1996) Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet. J Clin Endocrinol Metab 81:3599-3603
42. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC (1997) Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273-277
43. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R (1999) Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19:2364-2367
44. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC (1999) Health potential of soy isoflavones for menopausal women. Publ Health Nutr 2:489-504